The new face of nucleolin in human melanoma

被引:28
作者
Hoja-Lukowicz, Dorota [1 ]
Przybylo, Malgorzata [1 ]
Pochec, Ewa [1 ]
Drabik, Anna [2 ]
Silberring, Jerzy [2 ]
Kremser, Marcelina [1 ]
Schadendorf, Dirk [3 ]
Laidler, Piotr
Litynska, Anna [1 ]
机构
[1] Jagiellonian Univ, Inst Zool, PL-30060 Krakow, Poland
[2] Jagiellonian Univ, Fac Chem, Neurobiochem Dept, PL-30060 Krakow, Poland
[3] Univ Klinikum Essen, Klin Dermatol Venerol & Allergol, D-45122 Essen, Germany
关键词
Nucleolin; Melanoma; Tn antigen; SURFACE-EXPRESSED NUCLEOLIN; CELL-SURFACE; BINDING-PROTEIN; IN-VIVO; GLYCOSYLATION; TN; IDENTIFICATION; IMMUNOTHERAPY; CARBOHYDRATE; GLYCOPEPTIDE;
D O I
10.1007/s00262-009-0705-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Nucleolin is multifunctional protein mainly present in nucleoli but also detected in cytoplasm and plasma membranes. Extranuclear nucleolin differs from the nuclear form by its glycosylation. Studies on expression of nucleolin in breast cancer suggest a possible association to the metastatic cascade. In the present study, Vicia villosa lectin (VVL) precipitation followed by subsequent polyacrylamide gel electrophoresis and mass spectrometry analysis demonstrates nucleolin as a VVL-positive glycoprotein expressed in melanoma. The presence of VVL-positive nucleolin in the melanoma cell membrane and cytoplasm was confirmed by confocal microscopy. Using bioinformatic peptide prediction programs, nucleolin was shown to contain multiple possible MHC class-I binding peptides in its sequence which makes nucleolin an interesting melanoma marker and target for immunodiagnostic and possibly therapeutic purposes.
引用
收藏
页码:1471 / 1480
页数:10
相关论文
共 36 条
[1]   A fucose-containing O-glycoepitope on bovine and human nucleolin [J].
Aldi, Silvia ;
Giovampaola, Cinzia Della ;
Focarelli, Riccardo ;
Armini, Alessandro ;
Ziche, Marina ;
Finetti, Federica ;
Rosati, Floriana .
GLYCOBIOLOGY, 2009, 19 (04) :337-343
[2]  
Bubeník J, 2005, FOLIA BIOL-PRAGUE, V51, P1
[3]   Nucleolin undergoes partial N- and O-glycosylations in the extranuclear cell cornpartrnent [J].
Carpentier, M ;
Morelle, W ;
Coddeville, B ;
Pons, A ;
Masson, M ;
Mazurier, JL ;
Legrand, D .
BIOCHEMISTRY, 2005, 44 (15) :5804-5815
[4]  
CHEN CM, 1991, J BIOL CHEM, V266, P7754
[5]   Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels [J].
Christian, S ;
Pilch, J ;
Akerman, ME ;
Porkka, K ;
Laakkonen, P ;
Ruoslahti, E .
JOURNAL OF CELL BIOLOGY, 2003, 163 (04) :871-878
[6]  
Dall'olio F., 1996, Clin Mol Pathol, V49, P126
[7]   Internalization of anti-nucleolin antibody into viable HEp-2 cells [J].
Deng, JS ;
Ballou, B ;
Hofmeister, JK .
MOLECULAR BIOLOGY REPORTS, 1996, 23 (3-4) :191-195
[8]   Optimizing complement-activating antibody-based cancer immunotherapy: A feasible strategy? [J].
Fonsatti E. ;
Di Giacomo A.M. ;
Maio M. .
Journal of Translational Medicine, 2 (1)
[9]  
Ginisty H, 1999, J CELL SCI, V112, P761
[10]   Crystal structures of two H-2Db/glycopeptide complexes suggest a molecular basis for CTL cross-reactivity [J].
Glithero, A ;
Tormo, J ;
Haurum, JS ;
Arsequell, G ;
Valencia, G ;
Edwards, J ;
Springer, S ;
Townsend, A ;
Pao, YL ;
Wormald, M ;
Dwek, RA ;
Jones, EY ;
Elliott, T .
IMMUNITY, 1999, 10 (01) :63-74